iPSCs are pluripotent; unlike ESC, iPSCs are not derived from the embryo, but instead created from differentiated cells in the lab through a process – cellular reprogramming.
2. Background of iPSCs
Cellular differentiation has long been considered a
permanent process*
Specialized cell types were described as ‘terminally
differentiated’**
Shinya Yamanaka et al. (2006) – demonstrated
that differentiated skin cells could be turned back to
a pluripotent embryonic-like state – iPSCs***
3. Background of iPSCs
iPSCs are pluripotent; unlike ESC, iPSCs are
not derived from the embryo, but instead
created from differentiated cells in the lab
through a process – cellular
reprogramming.
4. Discovery of iPSCs
1. Yamanaka hypothesis
2. Testing of 24 possible pluripotency genes
3. Yamanaka factors: Oct4, Sox2, Klf4, c-Myc
4. Cellular reprogramming
5. How are the Yamanaka
Factors introduced into
cells?
6. Transgenics
The delivery of a sequence of genetic material
(transgene) into cells growing in a petri dish*
Retroviral vectors –modified viruses that
deliver foreign genetic material into a cell**
7. How do scientists know that
differentiated cells have been
reprogrammed into iPSCs?
8. Testing for Pluripotency
1. Morphology (cell shape)
2. Genomics (types of genes expressed)
3. Function (ability to differentiate)
9. Morphology
Change in morphology of the cells*
Example: skin cells grow as flattened cells in
a dish; however, as they become
reprogrammed, the iPSC grow in round
clumps known as colonies
10. Expression of pluripotency markers
Pluripotency markers
Genes that are only expressed in pluripotent
stem cells and not in other cell types.
Its expression resembles a molecular signature
that lets scientists know that cells have been
reprogrammed to a pluripotent state.
11. Function
Ability to differentiate into cell types of the 3
embryonic germ layers both in vitro and in vivo*
13. Tool to study human diseases
IPS cells are powerful method for creating
patient- and disease-specific cell lines for
research.
IPSCs are useful tools for drug development and
modeling diseases.
Scientists hope to use them in transplantation
medicine.
15. What is Cancer?
Abnormal cells in which the processes regulating
normal cell division are disrupted.
In cancer, the control systems that prevent cell
overgrowth & invasions are disabled.
They no longer require signals to induce cell
growth and division.
16. What is Cancer?
Acquire abnormal functions; develop new
characteristics – change in structure, decreased
cell adhesion & production of new enzymes.
17. Malfunctioning genes
Proto-oncogenes
Produce proteins that enhance cell division*
Tumor suppressors
Make proteins that normally prevent cell division or
cause cell death.
DNA repair genes
Help prevent mutations that lead to cancer.
18. Protein that stimulates cell cycle
Nucleus
Protein kinases
RAS (G protein)
Growth factor
Proto-oncogenes &
Signal transduction (RAS
pathway)
Transcription factor
19. Tumor suppressor genes
Mutations result in cells that no longer show
normal inhibition of cell growth and division.
Ex.: APC – mutations lead to FAP
20.
21. DNA repair genes
Involved in DNA repair and maintenance of
chromosome structure.
Environmental factors: ionizing radiation, UV light,
chemicals
Ex.: XP (mutation) – individuals who are sensitive to UV;
thousand-fold increase in incidence of all types of skin cancer
Bloom syndrome (BLM) – increased risk of cancer, lung
disease, and diabetes.
22. Cyclin-dependent kinases
Proteins that control timing
of events in cell cycle.
Kinase – adds phosphate to
various proteins required for
progression of cell cycle.
Specific CDK at enrty points
to G1,S, & M phases.
Loss of this regulation is the
hallmark of cancer.
p53 – stop cell cycle by
inhibiting CDK; mutation can
lead to cancer.
23. NORMAL CELLS CANCER CELLS
Require external growth factors to
divide*
They divide whether or not growth
factors are present**
Show contact inhibition*** Continue to grow after they touch other
cells, forming a large mass to form
The cells age and die, and replaced in
a controlled & orderly manner.
Unlimited number of cell divisions
(activation of telomerase).
Cease to divide and die when there is
DNA damage or when division is
abnormal
Continue to divide, even when there is
a large damage to DNA or when it is
abnormal
*This means that once a stem cell has differentiated into specialized cell, the specialized cell was thought to be trapped in that particular differentiated state.
**Specialized cells are incapable of becoming other cell types. This idea was challenged by a group of Japanese scientists led by Dr. Shinya Yamanaka, who demonstrated that differentiated skin cells could be turned back to a pluripotent embryonic-like state through genetic manipulation of the skin cells in the laboratory.
PLURIPOTENT: able to differentiate into all cells of the mature organism.
Yamanaka hypothesized that artificially forcing expression of the silenced pluripotency-related genes in differentiated skin cells would turn the specialized skin cells back into pluripotent embryonic-like.
Scientists in the Yamanaka lab began to artificially express the 24 candidate genes. They found out that only four factors were needed to reprogram mouse or human skin cells into iPSCs.
Yamanaka factors: naturally expressed in ESC, and are not expressed in differentiated cells.
Differentiated cells can be reprogrammed into an induced pluripotent state by artificial expression of four genes.
Transgenic expression of the Yamanaka Factors
*The transgene typically encodes for a protein that is not actively expressed in the host cell, but when the transgene is delivered into the cell, it becomes translated and the functional protein is artificially expressed.
**One way to deliver transgenes into cells; once delivered into the cell, the genetic material becomes integrated into the host cell’s genome for long-term expression of the transgene.
*The first that a differentiated cell has been reprogrammed into an iPSCs
*A key feature of pluripotent stem cells
Cancer cells
The abnormalities in cancer cells results from mutations in protein-encoding genes that regulate cell division.
CLASSIFICATIONS OF MALFUNCTIONING GENES
Of the approximately 35,000 genes in the human genome, only a small number have been associated with cancer. Alterations in the same gene often are associated with different forms of cancer.
*Produce proteins that normally inhibit normal cell death. Mutated forms are oncogenes.
In normal cells, the proto-oncogenes code for proteins that send signals to the nucleus to stimulate cell division.
This cascade includes a membrane receptor for the signal molecule, intermediary proteins (kinases) that carry the signal trough the cytoplasm, and transcription factors in the nucleus that activates the genes for cell division.
RAS is a proto-oncogene that functions normally as an “on-off” switch in the signal cascade. Mutations in RAS cause the signaling pathway to remain “on”, leading to uncontrolled cell growth. About 30% of tumors – lung, colon, thyroid, pancreatic carcinoma – have mutation in RAS.
Normally make proteins to inhibit cell growth.
Familial ademoatous polyposis
XP – Xeroderma pigmentosum
Normal cells grow and divide in an orderly fashion, in accordance with the cell cycle. (Mutations in proto-oncogenes or in tumor suppressor genes allow a cancerous cell to grow and divide without the normal controls imposed by the cell cycle.)
BLOCK allows time for the cell to repair the DNA before it is replicated.
In terms of cell division, normal cells differ from cancer cells in at least four ways.
*The cell stop dividing when these growth factors is inhibited.
**They do not behave as part of the tissue; they have become independent cells.
***They respond to contact with other cells by ceasing cell division.
• Carcinomas result from altered epithelial cells, which cover thesurface of our skin and internal organs. Most cancers are carcinomas.
• Sarcomas result from changes in muscle, bone, fat, orconnective tissue.
• Leukemia results from malignant white blood cells.
• Lymphoma is a cancer of the lymphatic system cells that derive from bone marrow.
• Myelomas are cancers of specialized white blood cells that make antibodies.